Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
CLDX holding history
Celldex Therapeutics, Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings
- Shares (Q2 2026)
- 103,695
- Value
- $3.86M
- % of portfolio
- 2.0%
- Quarters held
- 4
- Since Q3 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 103,695 | $3.86M | 2.0% | −27,669−21.1% | Reduced | Holders |
| Q1 2026 | 131,364 | $4.14M | 2.6% | −22,936−14.9% | Reduced | Holders |
| Q4 2025 | 154,300 | $4.19M | 3.6% | −700−0.5% | Reduced | Holders |
| Q3 2025 | 155,000 | $4.01M | 4.0% | +155,000 | New | Holders |